Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|October 1, 1996
Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patientsT Hanagiri, M Takenoyama, T Yoshimatsu, et al.
Immunology|March 1, 1996
Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodiesM Harada, T Okamoto, K Omoto, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|January 19, 2002
[Assessment of prognosis and p 53 mutations in patients with multiple tumors of the lung; intrapulmonary metastasis or double primary cancers?]T Osaki, T Oyama, M Takenoyama, et al.
International Journal of Cancer|January 27, 1997
Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free miceM Harada, K Matsunaga, Y Oguchi, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2M Harada, G Matsuzaki, Y Shinomiya, et al.
International Journal of Cancer|February 10, 1998
Systemic administration of interleukin-12 can restore the anti-tumor potential of B16 melanoma-draining lymph node cells impaired at a late tumor-bearing stateM Harada, K Tamada, K Abe, et al.
Cellular Immunology|March 1, 1995
The antitumor activity induced by the in vivo administration of activated B cells bound to anti-CD3 monoclonal antibodyM Harada, T Okamoto, S Kurosawa, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|November 24, 2011
A study of surgically resected peripheral non-small cell lung cancer with a tumor diameter of 1.0 cm or lessT Baba, H Uramoto, T Kuwata, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patientsH Uramoto, T Osaki, M Inoue, et al.
International Surgery|November 9, 2000
Pleural retraction and intra-tumoral air-bronchogram as prognostic factors for stage I pulmonary adenocarcinoma following complete resectionI Yoshino, R Nakanishi, M Kodate, et al.
Pageof 5